Search Results
The default setting for search results displays All Content. If you prefer to see recent content only, please adjust the date filter.
Filter your results:
Types
Topics
294 Results Found
TAKE ACTION: Urge Lawmakers to Reject Medicaid Cuts, Protect Access to Care
With your senators and representatives home in their states and districts for the next two weeks, please reach out to your lawmakers and urge them to reject funding cuts to Medicaid and other health care programs as part of reconciliation bill.
Contact Your Lawmakers and Urge Them to Extend Key Health Care Policies Set to Expire Next Month
Please ask your senators and representatives to prevent Medicaid disproportionate share hospital payment cuts from taking effect; extend enhanced low-volume adjustment and Medicare-dependent hospital programs that expand access to care in rural areas; and extend telehealth and hospital-at-home waivers.
AHA 340B Advocacy Alliance Bulletin - March 17, 2025
The Department of Health and Human Services said its decision to prevent drug companies from implementing a 340B rebate model “was within its statutory authority,” according to a department brief filed with the United States District Court for the District of Columbia.
HHS files brief in 340B rebate model case
The Department of Health and Human Services said its decision to prevent drug companies from implementing a 340B rebate model “was within its statutory authority,” according to a department brief filed March 17 with the United States District Court for the District of Columbia.
The 340B Drug Pricing Program
For more than 30 years, the 340B Drug Pricing Program has provided financial help to hospitals serving vulnerable communities to manage rising prescription drug costs. Despite significant oversight from HRSA and the program’s proven record of decreasing government spending and expanding access to patient care, some want to scale it back or drastically reduce the benefits that eligible hospitals and their patients receive from the program.
The 340B Program: How it Delivers Value to Patients and Providers
Over the past 30 years, the 340B Drug Pricing Program has played an essential role in ensuring health care providers have the neces
AHA 340B Advocacy Alliance Bulletin March 13, 2025
AHA 340B Advocacy Alliance Bulletin for March 13, 2025.
340B Benefits Patients and Communities: Examples from the Frontlines
The 340B Drug Pricing Program helps ensure access to care for patients and communities most in need. A bipartisan effort by Congress in 1992 designed the program to protect hospitals from rising drug costs — a dynamic that continues to present major challenges today.
AHA, others file amicus briefs opposing major drug companies’ 340B rebate models
The AHA has filed a number of friend-of-the-court briefs in cases before the U.S. District Court for the District of Columbia, urging the court to uphold the Health Resources and Services Administration’s decision to reject drug companies’ proposed 340B rebate models in separate lawsuits brought by a number of drug companies to bar the agency from doing so.
340B AHA Advocacy Alliance - March 7, 2025
AHA, others file amicus briefs opposing major drug companies’ 340B rebate models